M. Miura

Fully automated and highly specific plasma β-amyloid immunoassays predict β-amyloid status defined by amyloid positron emission tomography with high accuracy

A. Iwata, D. Verbel, Y. Irino, 2022, Alzheimer's research & therapy.

Analytical performance of a new automated chemiluminescent magnetic immunoassays for soluble PD-1, PD-L1, and CTLA-4 in human plasma

T. Yamasaki, M. Sonobe, H. Date, 2019, Scientific Reports.

Fully automated chemiluminescence enzyme immunoassays showing high correlation with immunoprecipitation mass spectrometry assays for β-amyloid (1-40) and (1-42) in plasma samples.

J. Matsui, Y. Irino, Tomokazu Yoshida, 2021, Biochemical and biophysical research communications.

Usefulness of plasma full-length glypican-3 as a predictive marker of hepatocellular carcinoma recurrence after radial surgery

Shinichirou Takahashi, N. Gotohda, M. Konishi, 2020, Oncology letters.

Analytical performance of a new automated chemiluminescent magnetic immunoassays for soluble PD-1, PD-L1, and CTLA-4 in human plasma

T. Yamasaki, M. Sonobe, H. Date, 2019, Scientific Reports.

Plasma and tumoral glypican‐3 levels are correlated in patients with hepatitis C virus‐related hepatocellular carcinoma

I. Endo, T. Matsuda, H. Toyoda, 2019, Cancer science.

Absorption, Metabolism, and Excretion of [ 14 C]Imidafenacin, a New Compound for Treatment of Overactive Bladder, After Oral Administration to Healthy Male Subjects

T. Ooie, S. Ohmori, M. Miura, 2007 .